government
La primera vacuna de ARNm contra la gripe para adultos mayores está aprobada en EE.UU. ¿Cómo se diferencia de la tradicional?
Summary by The El Paso Editorial Desk CNN Newsource , as published by KVIA ABC-7
· August 14, 2026
· 1 min read
Photo: KVIA ABC-7 · view original
Story provenance No corrections
Summary created by The El Paso Editorial Desk — automated, rule-governed Byline on source page CNN Newsource, as published by KVIA ABC-7 Original story Read at the source Source published Aug 14, 2026 Indexed here Aug 14, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway This vaccine is the first of its kind to use mRNA technology, similar to that used in many COVID-19 vaccines.
A new flu vaccine has been approved for use in adults 50 and older in the US. This vaccine is the first of its kind to use mRNA technology, similar to that used in many COVID-19 vaccines. The vaccine was developed by Moderna and approved by the US Food and Drug Administration.
It has faced a challenging path to approval, with initial funding cuts and a rejected review request. Further details about the vaccine and its development are available from the source, including information about the technology used and the approval process.
Why this matters
Local government decisions — zoning, budgets, ordinances, contracts — shape daily life more than most national headlines. The El Paso surfaces these stories so readers can engage with the bodies that affect their property, taxes, and neighborhood character.
About this story
As published by KVIA ABC-7 . The El Paso surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit KVIA ABC-7 . Have a tip or correction? Contact our newsroom .
Category: government Published: August 14, 2026 Source: KVIA ABC-7 Reading time: 1 min
Frequently asked about this story
What is this story about? A new flu vaccine has been approved for use in adults 50 and older in the US. This vaccine is the first of its kind to use mRNA technology, similar to that used in many COVID-19 vaccines. The vaccine…
When was this published? This article was first published on August 14, 2026 by KVIA ABC-7 and curated for The El Paso readers.
Who reported this story? This story was reported by CNN Newsource at KVIA ABC-7. To learn more about how The El Paso selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more government coverage from The El Paso, or browse our daily briefing and topic hubs .
← Back to all news
More government →
Today’s briefing
Subscribe to newsletter
